Antiviral and antiretroviral use in pregnancy

Obstet Gynecol Clin North Am. 2003 Dec;30(4):731-49, vii. doi: 10.1016/s0889-8545(03)00089-5.

Abstract

The history of antiviral and antiretroviral therapy is recent compared with many other medical therapies, including traditional antibiotics in pregnancy. There are few long-term data on which to base decisions of management in pregnancy. Accessing up-to-date information is critical to optimizing the safety of care for mothers and their infants. Exposure to medications in pregnancy can be toxic to a fetus in a gestational age-dependent manner. Determination of safe medications for pregnancy must take into consideration the need for certain medications and the possibility of inadvertent exposure in early pregnancy because of unplanned pregnancies. This article reviews the most commonly used antiviral and antiretroviral agents and places emphasis on the issues regarding use in pregnancy.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Retroviral Agents / adverse effects*
  • Anti-Retroviral Agents / therapeutic use*
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use*
  • Enzyme Inhibitors
  • Female
  • Foscarnet
  • HIV Infections / drug therapy
  • Humans
  • Interferons
  • Neuraminidase / antagonists & inhibitors
  • Nucleosides
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / virology*
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors

Substances

  • Anti-Retroviral Agents
  • Antiviral Agents
  • Enzyme Inhibitors
  • Nucleosides
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Foscarnet
  • Interferons
  • Neuraminidase